503 results on '"Bobik, Alex"'
Search Results
2. Quantitative proteomic landscape of unstable atherosclerosis identifies molecular signatures and therapeutic targets for plaque stabilization
3. Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes
4. Interferon regulatory factor 4 a master regulator of hypertensive kidney fibrosis and inflammation?
5. Myocarditis: causes, mechanisms, and evolving therapies
6. Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes
7. Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
8. Crosstalk between cytotoxic CD8+ T cells and stressed cardiomyocytes triggers development of interstitial cardiac fibrosis in hypertensive mouse hearts
9. An Ultrasound‐Responsive Theranostic Cyclodextrin‐Loaded Nanoparticle for Multimodal Imaging and Therapy for Atherosclerosis (Small 31/2022)
10. Killer cells in atherosclerosis
11. Abstract 14486: CD8αβ+ T Cells Promote Cardiac Fibrosis in Hypertensive Hearts via NKG2D Activating Receptor-Dependent Cytotoxic Mechanisms
12. Abstract 14497: B Cells are Major Contributors to Aggravated Atherosclerosis Following Myocardial Infarction
13. Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges
14. Protective Role of Natural IgM-Producing B1a Cells in Atherosclerosis
15. Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques
16. A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE−/− mice by reducing lesion necrosis and inflammation
17. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes
18. Immune regulation by CD52-expressing CD4 T cells
19. List of Contributors
20. Atherosclerosis
21. Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?
22. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms
23. The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture
24. Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes
25. Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms
26. Metalloproteinases and plasminogen activators in vessel remodeling
27. The tandem stenosis mouse model: Towards understanding, imaging, and preventing atherosclerotic plaque instability and rupture.
28. Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.
29. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis
30. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis
31. Hematopoietic Cell–Restricted Deletion of CD36 Reduces High-Fat Diet–Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue
32. B Cell and CD4 T Cell Interactions Promote Development of Atherosclerosis
33. Evolving BAFF targeted therapies for preventing acute myocardial infarctions and ischemic strokes
34. Low Tregs: A targetable risk factor for life-threatening cardiovascular complications after major noncardiac surgery
35. Early adaptive CD4+ T-cell immunity in atherosclerosis goes local
36. Urokinase Induces Matrix Metalloproteinase-9/Gelatinase B Expression in THP-1 Monocytes via ERK1/2 and Cytosolic Phospholipase A2 Activation and Eicosanoid Production
37. Urokinase Plasminogen Activator in Injured Adventitia Increases the Number of Myofibroblasts and Augments Early Proliferation
38. Myocardial endothelin-1 release and indices of inflammation during angioplasty for acute myocardial infarction and stable coronary artery disease
39. Serotonin blockade protects against early microvascular constriction following atherosclerotic plaque rupture
40. Contrasting Effects of Urokinase and Tissue-Type Plasminogen Activators on Neointima Formation and Vessel Remodelling after Arterial Injury
41. Mapping human pluripotent stem cell-endothelial cell differentiation using scRNA-seq: a step towards therapeutic angiogenesis
42. EFFECTS OF INTRACELLULAR Ca2+ CHELATING ON NORADRENALINE RELEASE IN NORMOXIC AND ANOXIC HEARTS
43. Alarmin-activated B cells accelerate murine atherosclerosis after myocardial infarction via plasma cell-immunoglobulin-dependent mechanisms.
44. REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING
45. VASCULAR REMODELLING AND MOLECULAR BIOLOGY: NEW CONCEPTS AND THERAPEUTIC POSSIBILITIES
46. REGULATION AND INTERACTIONS OF TRANSFORMING GROWTH FACTOR-β WITH CARDIOVASCULAR CELLS: IMPLICATIONS FOR DEVELOPMENT AND DISEASE
47. Mechanical strain stimulates a mitogenic response in coronary vascular smooth muscle cells via release of basic fibroblast growth factor
48. Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms
49. Response to balloon injury is vascular bed specific: A consequence of de novo vessel structure?
50. Alternative splicing within the TGF-β type I receptor gene (ALK-5) generates two major functional isoforms in vascular smooth muscle cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.